The effect of 1-day multidisciplinary clinic on breast cancer treatment
| العنوان: | The effect of 1-day multidisciplinary clinic on breast cancer treatment |
|---|---|
| المؤلفون: | F. Asrari, Amanda L. Blackford, Mehran Habibi, Zohaib Akhtar, Danijela Jelovac, Vered Stearns, Paul Cartwright, Catherine Klein, Vishnu Prasath |
| المصدر: | Breast Cancer Research and Treatment. 182:623-629 |
| بيانات النشر: | Springer Science and Business Media LLC, 2020. |
| سنة النشر: | 2020 |
| مصطلحات موضوعية: | 0301 basic medicine, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Breast Neoplasms, Stage ii, Time-to-Treatment, 03 medical and health sciences, 0302 clinical medicine, Time frame, Breast cancer, Patient age, Multidisciplinary approach, Internal medicine, Outcome Assessment, Health Care, medicine, Humans, skin and connective tissue diseases, Retrospective Studies, Patient Care Team, Chemotherapy, business.industry, Time to first treatment, Middle Aged, Prognosis, medicine.disease, Quality Improvement, Neoadjuvant Therapy, Survival Rate, 030104 developmental biology, Oncology, Median time, 030220 oncology & carcinogenesis, Female, Interdisciplinary Communication, business, Delivery of Health Care, Follow-Up Studies |
| الوصف: | A delay in breast cancer treatment is associated with inferior survival outcomes; however, no clear guidelines exist defining the appropriate time frame from diagnosis to definitive treatment of breast cancer. A multidisciplinary approach for breast cancer treatment can minimize the time from diagnosis to first treatment. We hypothesized single-day multidisciplinary clinic (MDC) may accelerate the time to first treatment on complex breast cancer cases at our institution. We identified patients who were treated at Johns Hopkins for stage II or III breast cancer, who were at least 18 years of age, and were seen in a new single-day MDC with coordination between two or three specialties or by specialists from varying disciplines on different days (IDC). Patients who initiated treatment between May 2015 (initiation of MDC clinic) and December 2017 were included in our study. A total of 296 patient records were reviewed independently. The mean (SD) patient age was 55 (13) years. The median time to first neoadjuvant chemotherapy (NACT) was significantly reduced for patients seen in the MDC (12.7 days), compared to those seen at the IDC (24.4 days, logrank p |
| تدمد: | 1573-7217 0167-6806 |
| DOI: | 10.1007/s10549-020-05721-3 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5f8153d36fb2d0b64debbc96b549395 https://doi.org/10.1007/s10549-020-05721-3 |
| Rights: | CLOSED |
| رقم الانضمام: | edsair.doi.dedup.....f5f8153d36fb2d0b64debbc96b549395 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 15737217 01676806 |
|---|---|
| DOI: | 10.1007/s10549-020-05721-3 |